Categories AlphaGraphs, Consumer, Earnings, U.S. Markets News
Procter & Gamble Q2 2019 earnings narrowly beat estimates
The Procter & Gamble Company (PG) reported upbeat earnings results for the second quarter of 2019 on Wednesday, January 23, before the market opened for regular trading.
Net profit soared 31% to $1.22 per diluted share in the quarter with US Tax Act impacting directly and via transitional charges. Core earnings rose 5% to $1.25 per share.
Net sales was $17.4 billion, almost identical to a year ago.
Beauty segment organic sales rose 8%, while Grooming segment organic sales slipped 3%. Health Care segment organic sales rose 5%, and Fabric and Home Care segment organic sales increased 6% for the quarter. Baby, Feminine and Family Care segment organic sales inched 3% up.
LOOKING FORWARD
In line with the quarterly performance, P&G spiked the higher end of its annual guidance for organic sales growth by 1%.
Organic sales growth is now estimated at 2-4% for fiscal 2019. The company now touts fiscal all-in sales to fall or rise 1%. “The net effect of acquisitions and divestitures should have a modest positive impact on all-in sales growth,” read the company statement.
Core earnings is expected to grow 3-8% per share for the year — taking an estimated $1.4 billion headwind from forex and higher commodity-transportation costs. GAAP diluted net EPS is expected to rise 17-24%.
P&G expects to pay over $7 billion in dividends and repurchase up to $5 billion of common shares.
P&G has been taking steps to revamp its product offerings while attempting to reduce costs. The company’s margins have been under pressure lately, and the increased investment costs are hurting margins. Negative impacts from currency fluctuations remain a threat to margins. As the giant goes deeper into 2019, let’s see how P&G will streamline its efforts to drive more value to its investors.
Browse through our earnings calendar and get all scheduled earnings announcements, analyst/investor conference and much more!
Most Popular
BIIB Earnings: Biogen Q1 2024 adj. earnings rise despite lower revenues
Biotechnology firm Biogen Inc. (NASDAQ: BIIB) Wednesday reported an increase in adjusted profit for the first quarter of 2024, despite a decline in revenues. Total revenue declined 7% year-over-year to
Hasbro (HAS) Q1 2024 Earnings: Key financials and quarterly highlights
Hasbro, Inc. (NASDAQ: HAS) reported first quarter 2024 earnings results today. Revenues decreased 24% year-over-year to $757.3 million. Net earnings attributable to Hasbro, Inc. were $58.2 million, or $0.42 per
BA Earnings: Highlights of Boeing’s Q1 2024 financial results
The Boeing Company (NYSE: BA) on Wednesday announced financial results for the first quarter of 2024, reporting a narrower net loss, on an adjusted basis. Revenues dropped 8%. Core loss,
Comments